ADBIOTECH Postpones Shareholder Meeting, Proposes Amendment to Articles and Election of Directors

ADBIOTECH amended its proxy solicitation statement, postponing the general shareholders meeting from June 5, 2026 to June 19, 2026.
The proposed amendment to the articles of incorporation expands business objectives from 53 to 69 items, adding biotechnology and medical service fields for diversification.
The agenda includes election of three inside directors and two outside directors; the changes are expected to have a neutral impact on shareholder value.
[AI Summary]No capital changes or dilution are involved, so existing shareholder value is not impacted; however, the effectiveness of business diversification through the charter amendment requires future monitoring.